Spectrophotometric Determination of Lacosamide in Bulk Drug and Oral Dosage Formulation

Authors

  • Vikramsinh R. Chauhan  Department of Chemistry, Sheth L.H. Science College, (Scholars of Gujarat University, Ahmedabad) Mansa, India
  • Deepshikha Sharma  Department of Chemistry, Sheth L.H. Science College, Mansa, Gujarat University, Ahmedabad, India.
  • Kartik B. Vyas  Department of Chemistry, Sheth L.H. Science College, Mansa, Gujarat University, Ahmedabad, India.

DOI:

https://doi.org//10.32628/IJSRST207262

Keywords:

Lacosamide, ICH, Spectrophotometric, Antiepileptic drugs

Abstract

A simple, rapid, cost effective and extractive UV-Vis spectrophotometric method has been developed for the determination of Lacosamide (LA) in bulk drug and pharmaceutical formulation. It was based on UV-Vis spectrophotometric measurements in which the drug reacts chromogenic reagent 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole in alkaline medium and give stable pale yellow colored complex which exhibits absorption maximum at 420 nm.  Beer’s law was obeyed in the concentration range of 0.04 - 40 μg /ml. This method was tested and validated for various parameters according to ICH guidelines. The proposed method was successfully applied for the determination of LA in oral formulation. The results demonstrated that the procedure is accurate, precise and reproducible (relative standard deviation < 2 %). As it is simple, cheap and less time consuming, it can be suitably applied for the estimation of LA in dosage forms in quality control labs.

References

  1. P. Kwan,M. J. Brodie. Early identification of refractory epilepsy. N Engl J Med. (2000). 342:314–319.
  2. S. Cortes, Z. K. Liao, D. Watson, H. Kohn. 1985. J Med Chem.(1985). 28:601–606.
  3. B. K. Beyreuther, J. Freitag, C. Heers, et al. CNS Drug Rev.Lacosamide: a review of preclinical properties. (2007). 13:21–42.
  4. D.Choi, J. P. Stables, H. Kohn.J Med Chem. (1996). 39:1907–1916.
  5. W. Cawello. Clin Pharmacokinet (2015). 54(9):901–14.
  6. G. A. McMillin,M. D.Krasowski.. Cambridge, MA: Elsevier, 2016;101–34.
  7. I. Malissin, F. J. Baud, M. Deveaux,S. Champion,N. Deye, B. Megarbane.Clin Toxicol. (2013). 51(4):381–2.
  8. W. Cawello, B. Rosenkranz, B. Schmid, W. Wierich.Epilepsia (2013). 54(3):530–6.
  9. C. Kestelyn, M. Lastelle, N. Higuet, S. Dell'Aiera, L. Staelens, P. Boulanger, et al.Bioanalysis (2011). 3(22):2515–22.
  10. J. Gonc_alves, G. Alves, J. Bicker, A. Falc~ao, A. Fortuna.Bioanalysis ( 2018). 10(8):541–57.
  11. D. Payto, N. Foldvary-Schaefer,N. So, M. Bruton, S. Wang.Bioanalysis (2014). 6(23):161–8.
  12. J. Kuhn, C.Knabbe.Talanta (2013). 110:71–80.
  13. P. Nikolaou, I.Papoutsis, C. Spiliopoulou,C. Voudris, . J Sep Sci (2015). 38(2):260–6.
  14. M. A. Korany, H. Mahgoub, R. S.Haggag, M. A. Ragab, O. A. Elmallah.J Chromatogr B( 2018).1083:75–85
  15. Atul Ajay Moghe, Thesis entitled Development of modern analytical methods in drug analysis, chapter 2, UV-VIS Spectroscopic determination of Rosiglitazone., (2002).
  16. ICH topics Q 2 A, validation of Analytical methods: Definitions and terminology, Geneva (1996).
  17. Seshamamba BSV, Sekaran CB, Glob Drugs Therap, 2017; 2: 1-8

International Journal of Scientific Research in Science and Technology

Downloads

Published

2019-05-20

Issue

Volume 6, Issue 3, May-June-2019

Section

Research Articles

License

Copyright (c) IJSRST

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

How to Cite

[1]
Vikramsinh R. Chauhan, Deepshikha Sharma, Kartik B. Vyas, " Spectrophotometric Determination of Lacosamide in Bulk Drug and Oral Dosage Formulation , International Journal of Scientific Research in Science and Technology(IJSRST), Online ISSN : 2395-602X, Print ISSN : 2395-6011, Volume 6, Issue 3, pp.370-376, May-June-2019. Available at doi : https://doi.org/10.32628/IJSRST207262